Top

Published in:

14-12-2023 | Type 2 Diabetes | Original Article

Diabetes-related distress and quality of life among people with type 2 diabetes at primary care level in Brazil

Authors: Natália Wilcesky Tosini Neves, Jéssica Silva Cunha Breder, Bruna Andrade Oliveira, Flávia Cristina Zanchetta, Joaquim Barreto, Andrei C. Sposito, Maria Helena Melo Lima

Published in: Acta Diabetologica | Issue 4/2024

Abstract

Purpose

Living with diabetes can be challenging, particularly when it comes to dealing with psychological distress and requiring self-care directives. Patients may feel frustrated, angry, overwhelmed, and discouraged. This study aimed to investigate the diabetes-related distress and quality of life among people with type 2 diabetes mellitus (T2DM).

Methods

A cross-sectional study carried out at the Clinical Research Centre at the University of Campinas, Brazil, between September 2020 and April 2021. Patients answered data regarding demographic and clinical variables, the Brazilian version of the Diabetes Distress Scale and the Diabetes Quality of Life (QOL) Measure by telephone contact. The data were managed using the RedCap System. For statistical analysis of the data, the Mann–Whitney and Kruskal–Wallis tests were applied for comparisons, and the Chi-square test for associations. The correlations were evaluated using the Spearman correlation coefficient.

Results

Out of the 302 participants we recruited, 50.33% exhibited significant diabetes-related distress. Those with elevated diabetes-related distress scores had shorter education levels (p < 0.05), lower HbA1c levels (p < 0.05), and lower total scores in Diabetes QOL Measure (p < 0.0001), particularly in the QOL impact (p < 0.0001), social/vocational worry (p < 0.05), and diabetes worry (p < 0.0001) subscales compared to the group with the lowest diabetes-related distress.

Conclusion

Elevated diabetes-related stress scores significantly affect patients’ QOL. Therefore, early screening of individuals at risk for this condition, using well-coordinated protocols, could mitigate adverse QOL effects and enhance their overall experience during disease management.

Ali S, Stone MA, Peters JL, Davies MJ, Khunti K (2006) The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabetic Med 23(11):1165–1173. https://doi.org/10.1111/J.1464-5491.2006.01943.XCrossRefPubMed

Perrin NE, Davies MJ, Robertson N, Snoek FJ, Khunti K (2017) The prevalence of diabetes-specific emotional distress in people with Type 2 diabetes: a systematic review and meta-analysis. Diabetic Med 34(11):1508–1520. https://doi.org/10.1111/DME.13448CrossRefPubMed

Snoek FJ, Bremmer MA, Hermanns N (2015) Constructs of depression and distress in diabetes: time for an appraisal. The Lancet Diabetes Endocrinol 3(6):450–460. https://doi.org/10.1016/S2213-8587(15)00135-7CrossRefPubMed

Fisher L, Gonzalez JS, Polonsky WH (2014) The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision. Diabetic Med: A J Br Diabetic Assoc 31(7):764–772. https://doi.org/10.1111/DME.12428CrossRef

Stoop CH, Nefs G, Pop VJ, Wijnands-van Gent CJM, Tack CJ, Geelhoed-Duijvestijn PHLM et al (2014) Diabetes-specific emotional distress in people with Type 2 diabetes: a comparison between primary and secondary care. Diabetic Med: A J Br Diabetic Assoc 31(10):1252–1259. https://doi.org/10.1111/DME.12472CrossRef

Young-Hyman D, De Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M (2016) Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care 39(12):2126–2140. https://doi.org/10.2337/DC16-2053CrossRefPubMedPubMedCentral

Péres DS, Santos MA, Zanetti ML, Ferronato AA (2007) Difficulties of diabetic patients in the control of illness control: feelings and behaviors. Rev Lat Am Enfermagem 15(6):1105–1112. https://doi.org/10.1590/s0104-11692007000600008CrossRefPubMed

Gonzalez JS, Tanenbaum ML, Commissariat PV (2016) Psychosocial factors in medication adherence and diabetes self-management: implications for research and practice. Am Psychol 71(7):539–551. https://doi.org/10.1037/a0040388CrossRefPubMedPubMedCentral

Zurita-Cruz JN, Manuel-Apolinar L, Arellano-Flores ML, Gutierrez-Gonzalez A, Najera-Ahumada AG, Cisneros-González N (2018) Health and quality of life outcomes impairment of quality of life in type 2 diabetes mellitus: a cross-sectional study. Health Qual Life Outcomes. https://doi.org/10.1186/S12955-018-0906-YCrossRefPubMedPubMedCentral

10.

Shrestha B, Dunn L (2020) The declaration of Helsinki on medical research involving human subjects: a review of seventh revision. J Nepal Health Res Counc 17(4):548–552. https://doi.org/10.33314/JNHRC.V17I4.1042CrossRefPubMed

11.

Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J et al (2005) Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care 28(3):626–631. https://doi.org/10.2337/DIACARE.28.3.626CrossRefPubMed

12.

Curcio R, Alexandre NMC, De Carvalho TH, Lima MHM (2012) Translation and adaptation of the “Diabetes Distress Scale in Brazilian culture. Acta Paul Enferm 25(5):762–767. https://doi.org/10.1590/S0103-21002012005000025CrossRef

13.

Schmitt A, Reimer A, Kulzer B, Haak T, Ehrmann D, Hermanns N (2016) How to assess diabetes distress: comparison of the Problem Areas in Diabetes Scale (PAID) and the Diabetes Distress Scale (DDS). Diabet Med 33(6):835–843. https://doi.org/10.1111/DME.12887CrossRefPubMed

14.

Correr CJ, Pontarolo R, Melchiors AC, Rossignoli P, Fernández-Llimós F, Radominski RB (2008) Translation to Portuguese and validation of the Diabetes Quality Of Life Measure (DQOL-Brazil. Arq Bras Endocrinol Metabol 52(3):515–522. https://doi.org/10.1590/s0004-27302008000300012CrossRefPubMed

15.

Medronho RA, Carvalho D, Bloch K V, Luiz R, Werneck G (2005) Epidemiologia. Ed. Atheneu. São Paulo

16.

Pagano M, Gauvreau K Mattie H (2022) Principles of Biostatistics (3rd ed). Chapman and Hall/CRC. https://doi.org/10.1201/9780429340512

17.

Cohen J (1992) A power primer. Psychol Bull 112(1):155–159. https://doi.org/10.1037/0033-2909.112.1.155CrossRefPubMed

18.

American Diabetes Association Professional Practice Committee (2022) 13. Older adults: standards of medical care in diabetes-2022. Diabetes Care 45(Suppl 1):S195–S207. https://doi.org/10.2337/DC22-S013CrossRef

19.

Apolinario PP, Trevisan DD, Matheus Rodrigues RC, Jannuzzi FF, Ferreira JF, de Oliveira HC et al (2016) Psychometric performance of the Brazilian Version of the Diabetes Distress Scale in patients with diabetes mellitus type 2. J Nurs Measur 24(2):101E-113E. https://doi.org/10.1891/1061-3749.24.2.E101CrossRef

20.

Nguyen VB, Tran TT, Dang TL, Nguyen VVH, Tran BT, Van Le C et al (2020) Diabetes-related distress and its associated factors among patients with diabetes in Vietnam. Psychol Res Behav Manag 13:1181–1189. https://doi.org/10.2147/PRBM.S285291CrossRefPubMedPubMedCentral

21.

Huynh G, Tran TT, Do THT, Truong TTD, Ong PT, Nguyen TNH et al (2021) Diabetes-related distress among people with type 2 diabetes in Ho Chi Minh City, Vietnam: prevalence and associated factors. Diabetes Metab Syndr Obesity: Targets Ther 14:683–690. https://doi.org/10.2147/DMSO.S297315CrossRef

22.

Fisher L, Polonsky WH, Hessler DM, Masharani U, Blumer I, Peters AL et al (2015) Understanding the sources of diabetes distress in adults with type 1 diabetes. J Diabetes Complic 29(4):572–577. https://doi.org/10.1016/J.JDIACOMP.2015.01.012CrossRef

23.

Kuniss N, Rechtacek T, Kloos C, Müller UA, Roth J, Burghardt K et al (2017) Diabetes-related burden and distress in people with diabetes mellitus at primary care level in Germany. Acta Diabetol 54(5):471–478. https://doi.org/10.1007/S00592-017-0972-3CrossRefPubMed

24.

Parsa S, Aghamohammadi M, Abazari M (2019) Diabetes distress and its clinical determinants in patients with type II diabetes. Diabetes Metab Syndr 13(2):1275–1279. https://doi.org/10.1016/J.DSX.2019.02.007CrossRefPubMed

25.

Seligman HK, Tschann J, Jacobs EA, Fernandez A, López A (2012) Food insecurity and glycemic control among low-income patients with type 2 diabetes. Diabetes Care 35(2):233–238. https://doi.org/10.2337/DC11-1627CrossRefPubMedPubMedCentral

26.

Cuddapah GV, Vallivedu Chennakesavulu P, Pentapurthy P, Vallakati M, Kongara A, Reddivari P et al (2022) Complications in diabetes mellitus: social determinants and trends. Cureus. https://doi.org/10.7759/CUREUS.24415CrossRefPubMedPubMedCentral

27.

Sittner KJ, Greenfield BL, Walls ML (2018) Microaggressions, diabetes distress, and self-care behaviors in a sample of American Indian adults with type 2 diabetes. J Behav Med 41(1):122–129. https://doi.org/10.1007/S10865-017-9898-ZCrossRefPubMed

28.

Chew BH, Mohd-Sidik S, Shariff-Ghazali S (2015) Negative effects of diabetes-related distress on health-related quality of life: an evaluation among the adult patients with type 2 diabetes mellitus in three primary healthcare clinics in Malaysia. Health Qual Life Outcomes. https://doi.org/10.1186/S12955-015-0384-4CrossRefPubMedPubMedCentral

29.

Aljuaid MO, Almutairi AM, Assiri MA, Almalki DM, Alswat K (2018) Diabetes-related distress assessment among type 2 diabetes patients. J Diabetes Res 2018:1–10. https://doi.org/10.1155/2018/7328128CrossRef

30.

Fukuda N, Krupa G, Lim E, Leake A (2019) Validation of the diabetes distress scale in an Asian Pacific islander population. Hawai’i J Med Public Health 78(1):3. https://pubmed.ncbi.nlm.nih.gov/30697468/. Accessed 13 Jul 2023

31.

Johnson ST, Al Sayah F, Mathe N, Johnson JA (2016) The relationship of diabetes-related distress and depressive symptoms with physical activity and dietary behaviors in adults with type 2 diabetes: a cross-sectional study. J Diabetes Complic 30(5):967–970. https://doi.org/10.1016/J.JDIACOMP.2016.02.019CrossRef

32.

Kintzoglanakis K, Vonta P, Copanitsanou P (2020) Diabetes-related distress and associated characteristics in patients with type 2 diabetes in an urban primary care setting in Greece. Chronic Stress. https://doi.org/10.1177/2470547020961538CrossRefPubMedPubMedCentral

33.

Gómez-Pimienta E, González-Castro TB, Fresan A, Juárez-Rojop IE, Martínez-López MC, Barjau-Madrigal HA et al (2019) Decreased quality of life in individuals with type 2 diabetes mellitus is associated with emotional distress. Int J Environ Res Public Health. https://doi.org/10.3390/IJERPH16152652CrossRefPubMedPubMedCentral

34.

Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T (2006) How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia 49(3):469–477. https://doi.org/10.1007/S00125-005-0094-2CrossRefPubMed

35.

Adriaanse MC, Dekker JM, Spijkerman AMW, Twisk JWR, Nijpels G, Van Der Ploeg HM et al (2005) Diabetes-related symptoms and negative mood in participants of a targeted population-screening program for type 2 diabetes: the Hoorn Screening Study. Qual Life Res: An Int J Qual--Life Aspects Treat, Care Rehab 14(6):1501–1509. https://doi.org/10.1007/S11136-004-0028-3CrossRef

Title: Diabetes-related distress and quality of life among people with type 2 diabetes at primary care level in Brazil
Authors: Natália Wilcesky Tosini Neves
Jéssica Silva Cunha Breder
Bruna Andrade Oliveira
Flávia Cristina Zanchetta
Joaquim Barreto
Andrei C. Sposito
Maria Helena Melo Lima
Publication date: 14-12-2023
Publisher: Springer Milan
Keyword: Type 2 Diabetes
Published in: Acta Diabetologica / Issue 4/2024
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-023-02216-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2024

Downregulation of Sirt3 contributes to β-cell dedifferentiation via FoxO1 in type 2 diabetic mellitus

Downregulating lncRNA MIAT attenuates apoptosis of podocytes exposed to high glucose

Retinal neurodegeneration in diabetic retinopathy with systemic hypertension

AdultCarbQuiz for the Portuguese population with type 1 diabetes mellitus: translation, cultural adaptation and validation of its metabolic impact

Association between continuous glucose monitoring-derived glycemic control indices and urinary biomarkers of diabetic kidney disease: Hyogo Diabetes Hypoglycemia Cognition Complications study

Assessing early tubular protective effects of SGLT2 inhibitor empagliflozin against type 2 diabetes mellitus using functional magnetic resonance imaging

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials